Contact
searchSearch
HMP Global

Q&As

Joseph F. Merola, MD, MMSc
Q&As
A New Era in Dermatomyositis: A Conversation at the Rheumatology-Dermatology Interface
09/16/2026
Joseph F. Merola, MD, MMSc; Katharina S. Shaw, MD, FAAD
Masterclasses in Dermatology Co-Chair Dr Joseph Merola chats with Dr Katharina Shaw, SVP, Dermatology Franchise, Priovant Therapeutics, about the recent FDA approval of Lisraya as the first oral therapy for adult dermatomyositis.
Masterclasses in Dermatology Co-Chair Dr Joseph Merola chats with Dr Katharina Shaw, SVP, Dermatology Franchise, Priovant Therapeutics, about the recent FDA approval of Lisraya as the first oral therapy for adult dermatomyositis.
Masterclasses in Dermatology...
09/16/2026
The Dermatologist
sunscreen
Q&As
FDA Approves Bemotrizinol: What Dermatologists Need to Know
06/11/2026
Jane Y. Yoo, MD; Riya Gandhi, MA
The Dermatologist spoke with Dr Jane Yoo about the FDA’s landmark approval of bemotrizinol.
The Dermatologist spoke with Dr Jane Yoo about the FDA’s landmark approval of bemotrizinol.
The Dermatologist spoke with Dr...
06/11/2026
The Dermatologist
Omar Ibrahimi, MD, PhD
Q&As
Laser Focused: The Latest Trends in Laser and Light Devices
05/15/2026
Omar A. Ibrahimi, MD, PhD; Riya Gandhi, MA
In this Expert Q&A, Dr Ibrahimi highlights the technologic advancements that are reshaping clinical practice.
In this Expert Q&A, Dr Ibrahimi highlights the technologic advancements that are reshaping clinical practice.
In this Expert Q&A, Dr Ibrahimi...
05/15/2026
The Dermatologist
Omar Ibrahimi, MD, PhD
Q&As
Devices I Can’t Live Without and What I’m Excited About in 2026
05/14/2026
Omar A. Ibrahimi, MD, PhD; Riya Gandhi, MA
In this expert Q&A, Dr Ibrahimi offers insight into energy-based technologies from trusted lasers for resurfacing and vascular conditions to emerging advancements like focal point technology.
In this expert Q&A, Dr Ibrahimi offers insight into energy-based technologies from trusted lasers for resurfacing and vascular conditions to emerging advancements like focal point technology.
In this expert Q&A, Dr Ibrahimi...
05/14/2026
The Dermatologist
Omar Ibrahimi
Q&As
Scar Revision Strategies: When to Intervene and the Role of Laser Therapy
04/27/2026
Omar A. Ibrahimi, MD, PhD; Riya Gandhi, MA
This expert Q&A explores when scar revision is warranted, from functional impairment to patient-driven concerns.
This expert Q&A explores when scar revision is warranted, from functional impairment to patient-driven concerns.
This expert Q&A explores when...
04/27/2026
The Dermatologist
Jane Yoo
Q&As
Sunscreen Filters: What’s New in UVA Protection, Formulations, and Global Options
03/17/2026
Jane Y. Yoo, MD
Explore the latest advances in sunscreen filter technology, including improved UVA coverage, photostability, and cosmetic formulations that enhance patient adherence.
Explore the latest advances in sunscreen filter technology, including improved UVA coverage, photostability, and cosmetic formulations that enhance patient adherence.
Explore the latest advances in...
03/17/2026
The Dermatologist
Part 3
Q&As
Rebuilding Confidence in Alopecia Areata: Multidisciplinary, Holistic Support for Patients and Families
11/03/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
Experts explore holistic and emotional support strategies to empower patients with alopecia areata—beyond medicine, toward identity and healing.
Experts explore holistic and emotional support strategies to empower patients with alopecia areata—beyond medicine, toward identity and healing.
Experts explore holistic and...
11/03/2025
The Dermatologist
part 2
Q&As
Part 2: Advancing the Treatment Landscape in Severe Alopecia Areata
09/01/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
In Part 2 of this expert interview series, Dr Brittany Craiglow, Dr Brett King, and Dr Maryanne Senna explore the latest treatment strategies for severe alopecia areata.
In Part 2 of this expert interview series, Dr Brittany Craiglow, Dr Brett King, and Dr Maryanne Senna explore the latest treatment strategies for severe alopecia areata.
In Part 2 of this expert...
09/01/2025
The Dermatologist
Part 1 roundtable
Q&As
Part 1: Understanding the Emotional and Physical Toll of Alopecia Areata
08/04/2025
Brittany Craiglow, MD; Brett A. King, MD, PhD; Maryanne Makredes Senna, MD
In this candid and powerful conversation, Dr Brittany Craiglow, Dr Brett King, and Dr Maryanne Senna share their clinical experiences treating patients with severe alopecia areata.
In this candid and powerful conversation, Dr Brittany Craiglow, Dr Brett King, and Dr Maryanne Senna share their clinical experiences treating patients with severe alopecia areata.
In this candid and powerful...
08/04/2025
The Dermatologist
Brandon Adler, MD
Q&As
Insights Into Photoprotection Updates
02/08/2024
Jessica Garlewicz
Dr Brandon Adler shared the latest updates in sunscreen usage, and how physicians can implement these changes in their practices.
Dr Brandon Adler shared the latest updates in sunscreen usage, and how physicians can implement these changes in their practices.
Dr Brandon Adler shared the...
02/08/2024
The Dermatologist

Popular Articles

Aesthetics Corner
The Future of Regenerative Medicine: Innovations to Watch
10/07/2024
Riya Gandhi, MA
Gain key insights on emerging technologies and their potential impact on patient care.
Gain key insights on emerging technologies and their potential impact on patient care.
Gain key insights on emerging...
10/07/2024
The Dermatologist
Hidradenitis Suppurativa
News
Evolving Treatment Paradigms for Hidradenitis Suppurativa: The Role of Biologics
10/31/2024
Jessica Garlewicz
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS includes both topical and systemic medications, as well as a variety of surgical interventions.
Currently, treatment for HS...
10/31/2024
The Dermatologist
Jeffrey M. Cohen, MD
Conference Coverage
TYK2 as a Therapeutic Target in Psoriasis
08/11/2025
Coleen Stern, MA
Jeffrey M. Cohen, MD, discussed TYK2 inhibitors, a new class of therapy being studied for the treatment of psoriasis.
Jeffrey M. Cohen, MD, discussed TYK2 inhibitors, a new class of therapy being studied for the treatment of psoriasis.
Jeffrey M. Cohen, MD, discussed...
08/11/2025
The Dermatologist
Clinical Insights
Strategies for Managing Pediatric Atopic Dermatitis
10/07/2024
Riya Gandhi, MA
“The list of things that we can consider for our pediatric patients is growing by the month, and that is very exciting,” says Dr Lisa Swanson.
“The list of things that we can consider for our pediatric patients is growing by the month, and that is very exciting,” says Dr Lisa Swanson.
“The list of things that we can...
10/07/2024
The Dermatologist
rosacea
News
Consensus on a Core Outcome Set for Rosacea in Clinical Trials and Practice
10/31/2024
Riya Gandhi, MA
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes could facilitate more effective data comparison across studies, improving research and clinical care for rosacea.
A standardized set of outcomes...
10/31/2024
The Dermatologist
september 2026

Current Issue

September 2026
Volume 34
Issue 6
Current Issue
Issue Archive

Latest Quizzes and Trivia

itch
Quiz
Clinical Implications of Type 2 Inflammation in Chronic Spontaneous Urticaria
09/21/2026
Riya Gandhi, MA
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of disease fluctuation, neuroimmune signaling, cytokine biology, and targeted therapeutic strategies in chronic spontaneous urticaria.
Evaluate your understanding of...
09/21/2026
The Dermatologist
random molecule
Quiz
Understanding Type 2 Inflammatory Mechanisms in Chronic Spontaneous Urticaria
09/14/2026
Riya Gandhi, MA
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of cytokine signaling, mast cell biology, neuroimmune interactions, and the mechanisms that drive chronic spontaneous urticaria.
Test your understanding of...
09/14/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: Biologic Therapy Challenges in Children
08/10/2026
Riya Gandhi, MA
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of biologic therapy in pediatric atopic dermatitis with this expert quiz. Explore practical barriers to treatment, considerations for young children and caregivers, and real-world factors that influence successful...
Assess your understanding of...
08/10/2026
The Dermatologist
AD
Quiz
Pediatric AD Quiz: When to Escalate to Systemic Therapy
08/10/2026
Riya Gandhi, MA
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment escalation in pediatric atopic dermatitis. This clinical quiz explores when topical therapy is no longer sufficient and when to initiate systemic treatment in children.
Test your knowledge of treatment...
08/10/2026
The Dermatologist
Quiz
Type 2 Endotypes and Therapeutic Strategy in Prurigo Nodularis
06/25/2026
Riya Gandhi, MA
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type 2 inflammatory endotypes, shared therapeutic pathways, and practical treatment approaches in prurigo nodularis.
Assess advanced concepts in type...
06/25/2026
The Dermatologist
itch
Quiz
Fibrosis and Persistent Itch in Prurigo Nodularis
06/15/2026
Riya Gandhi, MA
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding of fibrotic remodeling and the mechanisms underlying persistent itch and chronic disease activity in prurigo nodularis.
Test your clinical understanding...
06/15/2026
The Dermatologist
brain
Quiz
Neuroimmune Mechanisms and Cytokine Signaling in Prurigo Nodularis
06/05/2026
Riya Gandhi, MA
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in neuroimmune communication, cytokine-driven itch amplification, and fibrotic signaling pathways involved in prurigo nodularis.
Explore advanced concepts in...
06/05/2026
The Dermatologist
Quiz
Predicting Disease Severity and Persistence in Pediatric Atopic Dermatitis
04/15/2026
Riya Gandhi, MA
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in identifying risk factors for persistent pediatric atopic dermatitis and understanding the interplay between barrier dysfunction and immune dysregulation.
Test your expertise in...
04/15/2026
The Dermatologist
Quiz
Type 2 Inflammation and Early Systemic Therapy in Pediatric Atopic Dermatitis
04/05/2026
Riya Gandhi, MA
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical reasoning in pediatric atopic dermatitis, including implications of type 2 inflammation for diagnosis, treatment timing, and systemic therapy decisions.
Assess advanced clinical...
04/05/2026
The Dermatologist
Quiz
Disease Heterogeneity in PN
03/15/2026
Riya Gandhi, MA
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of direct and indirect cytokine–nerve interactions and mechanical hypersensitivity of type 2 signaling in prurigo nodularis.
Challenge your understanding of...
03/15/2026
The Dermatologist

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use